title: Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis.
abstract: Erythropoiesis-stimulating agents (ESAs) reduce anemia in patients with cancer and could improve their quality of life, but ESA-related safety concerns exist. To evaluate the overall risk of venous thromboembolism (VTE) associated with the use of ESAs, a systematic review and meta-analysis of published randomized controlled trials (RCTs) was performed. The databases of PubMed and Web of Science and the abstracts presented at the American Society of Clinical Oncology conferences were searched to identify relevant clinical trials. Summary incidence rates, relative risks (RRs), and 95% confidence intervals (CIs) were calculated. A total of 12,115 patients with a variety of cancer types from 51 RCTs were identified and included in the meta-analysis. Among patients receiving ESAs, the summary incidence of all-grade VTE was 7.78%. Patients with cancer who received ESAs had increased VTE risks (484 events among 6,301 patients treated with ESA vs. 276 events among 5,814 control patients; RR = 1.75 [95% CI, 1.50–2.05]). The highest risk of VTE was found in patients with ovarian and cervical cancers (RR = 2.45 [CI = 1.12–5.33]). The VTE risk among hematologic malignancies was higher than that among solid tumors. The administration of ESAs was significantly associated with an increased risk of developing VTE in cancer patients receiving these drugs. The risks of VTE may vary with various tumor types, including hematologic malignancies.
authors: Sheng
authors: S
authors: Gao
authors: Jing-Jing
authors: JJ
authors: Ma
authors: Cheng
authors: C
authors: Lu
mesh_terms: D000740:Anemia / Q000188:drug therapy / Q000209:etiology*; D017326:Clinical Trials, Phase III as Topic; D006397:Hematinics / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000150:complications* / Q000175:diagnosis; D016017:Odds Ratio; D017594:Publication Bias; D012306:Risk; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000209:etiology*
chemical_list: D006397:Hematinics
references: Stat Med. 2002 Jun 15;21(11):1539-58
references: 12111919
references: Ann Oncol. 2009 Jun;20(6):1105-12
references: 19174452
references: Br J Haematol. 2005 Apr;129(2):206-9
references: 15813848
references: Biometrics. 1994 Dec;50(4):1088-101
references: 7786990
references: Oncologist. 2010;15(9):935-43
references: 20798194
references: Blood. 1996 Apr 1;87(7):2675-82
references: 8639883
references: J Clin Oncol. 2001 Jun 1;19(11):2865-74
references: 11387359
references: Br J Cancer. 2003 Jun 16;88(12):1851-8
references: 12799626
references: Cancer J Sci Am. 1995 Nov-Dec;1(4):261-6
references: 9166486
references: J Clin Oncol. 2009 Dec 1;27(34):5751-6
references: 19884550
references: J Clin Oncol. 2005 Apr 20;23(12):2606-17
references: 15452187
references: Control Clin Trials. 1986 Sep;7(3):177-88
references: 3802833
references: J Natl Cancer Inst. 2008 Aug 20;100(16):1155-66
references: 18695134
references: Br J Cancer. 2011 Oct 25;105(9):1267-72
references: 21959870
references: J Clin Oncol. 2006 Oct 10;24(29):4675-6
references: 17028292
references: Eur J Clin Invest. 2005 Dec;35 Suppl 3:26-31
references: 16281955
references: Cancer Biol Ther. 2009 Jan;8(1):13-7
references: 18981719
references: Eur J Cancer. 1993;29A Suppl 2:S2-8
references: 8398361
references: J Thromb Haemost. 2007 Mar;5(3):632-4
references: 17319909
references: Cancer. 2012 Feb 1;118(3):848-55
references: 21751205
references: J Clin Oncol. 2011 Oct 1;29(28):3791-7
references: 21860000
references: Oncology. 2003;64(2):102-10
references: 12566906
references: Cancer. 2001 Jun 15;91(12):2214-21
references: 11413508
references: J Clin Oncol. 1994 May;12(5):1058-62
references: 8164030
references: Jpn J Clin Oncol. 2009 Mar;39(3):163-8
references: 19164318
references: Semin Oncol. 1994 Apr;21(2 Suppl 3):21-8
references: 8202722
references: Lancet. 2003 Oct 18;362(9392):1255-60
references: 14575968
references: J Pain Symptom Manage. 2004 Feb;27(2):185-90
references: 15157043
references: Eur J Cancer. 2004 Oct;40(15):2293-306
references: 15454256
references: Mol Cancer Ther. 2006 Feb;5(2):356-61
references: 16505109
references: J Clin Oncol. 2005 Dec 20;23(36):9377-86
references: 16361638
references: BMJ. 1997 Sep 13;315(7109):629-34
references: 9310563
references: Br J Haematol. 2001 Apr;113(1):172-9
references: 11328297
references: Clin Cancer Res. 2006 Jan 15;12(2):332-9
references: 16428469
references: J Natl Cancer Inst. 2001 Aug 15;93(16):1204-14
references: 11504766
references: Onkologie. 2009 Apr;32(4):168-74
references: 19372711
references: J Clin Oncol. 2006 Oct 10;24(29):4708-13
references: 17028293
references: Med Oncol. 1998 Sep;15(3):174-82
references: 9819794
references: J Clin Oncol. 2007 Mar 20;25(9):1027-32
references: 17312332
references: J Natl Cancer Inst. 2008 Oct 1;100(19):1344-51
references: 18812542
references: Cancer Res. 2001 May 1;61(9):3561-5
references: 11325818
references: Melanoma Res. 2006 Aug;16(4):275-83
references: 16845323
references: J Clin Oncol. 2005 Sep 1;23(25):5960-72
references: 16087945
references: Oncogene. 2005 Jun 23;24(27):4442-9
references: 15856028
references: Curr Med Res Opin. 2009 Sep;25(9):2109-20
references: 19601709
references: J Natl Cancer Inst. 1993 May 19;85(10):801-6
references: 8487324
references: Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv
references: 17408534
references: J Clin Oncol. 2008 May 10;26(14):2342-9
references: 18467726
references: Am J Pathol. 2005 Mar;166(3):823-30
references: 15743794
references: Ann Oncol. 2011 Sep;22(9):1999-2006
references: 21382868
references: J Natl Cancer Inst. 2006 May 17;98(10):708-14
references: 16705125
references: Br J Cancer. 2006 Apr 10;94(7):947-54
references: 16570051
references: Br J Cancer. 1999 May;80(3-4):396-402
references: 10408844
references: JAMA. 2008 Feb 27;299(8):914-24
references: 18314434
references: J Natl Cancer Inst. 2002 Aug 21;94(16):1211-20
references: 12189224
references: Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17
references: 17716826
references: J Clin Oncol. 2008 Feb 1;26(4):592-8
references: 18235117